Dealmaking was strong among molecular diagnostics (MDx) players during 2021 despite the continuation of the pandemic, with most merger and acquisition (M&A) transactions demonstrating either a pivot ...
DELRAY BEACH, Fla., Sept. 19, 2025 /PRNewswire/ -- The global In Vitro Diagnostics Quality Control Market, valued at US$1.58 billion in 2024, stood at US$1.65 billion in 2025 and is projected to ...
Clinical Utility of Pharmacogenomics and Genetic Testing Remains an Issue Through rapid advances in research and clinical applications, molecular diagnostics has grown from a genomic and proteomic ...
SALT LAKE CITY, Utah--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, ...
The In Vitro Diagnostics (IVD) Quality Control Market is driven by the increasing prevalence of chronic and infectious diseases, growing adoption of point-of-care testing, and technological ...
Dublin, Sept. 26, 2025 (GLOBE NEWSWIRE) -- The "Molecular Diagnostics Market Industry Trends and Global Forecasts to 2035: Distribution by Test Type, Type of Offering, Type of Sample, Type of ...
The current pandemic has impacted nearly every aspect of daily life. One strategy to help public health professionals understand and control the spread of SARS-CoV-2 is the widespread testing of ...
BOSTON & OXFORD, England & CAMBRIDGE, England & TORONTO--(BUSINESS WIRE)--Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has entered into a strategic agreement ...
An important scientific study published in The Lancet shows the strong public health impact of deploying molecular diagnostics closer to the people.
Renal tumor pathology has evolved considerably, expanding from two main types of renal malignant tumors to over 20 distinct types. Diagnostic criteria have advanced from purely morphological features ...
A look at the shareholders of Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) can tell us which group is most powerful. With 50% stake, hedge funds possess the maximum shares in the company. That is, ...